Drug, Food and Supplement Interactions — With Trastuzumab

No. ASCO and ESMO guidance consistently recommends against giving anthracyclines such as doxorubicin concurrently with trastuzumab. Both affect the heart, and the combined cardiac risk is substantially higher than either drug given alone. Most regimens sequence them — anthracyclines first, then trastuzumab after a gap — rather than overlapping them. If your plan includes both, ask your oncologist how the sequencing will be handled and what cardiac monitoring is in place.

Paracetamol at normal doses is generally considered safer than anti-inflammatory painkillers during trastuzumab treatment. NSAIDs such as ibuprofen and diclofenac are not directly contraindicated, but they can mask early cardiac symptoms and interact with other drugs in your regimen. Tell your oncology team before using any painkiller regularly — including one bought over the counter — so they can advise based on your full treatment plan.

Some can. Herbal preparations — including Ayurvedic, Unani and Siddha formulations — can affect cardiac function, alter how other drugs in your regimen behave, or interact with blood thinners you may already be taking. St John's Wort in particular is known to alter drug metabolism significantly and is not recommended alongside most cancer treatments. Many traditional preparations contain pharmacologically active compounds, so your oncologist needs a complete list before each infusion. This is not a judgement on the practice — it is information your team needs to keep you safe.

Trastuzumab does not have a well-documented direct interaction with warfarin, but patients on anticoagulants need close monitoring throughout cancer treatment. Other drugs in your regimen, dietary changes, and the disease itself can all shift clotting levels, making dose adjustment necessary. Tell your oncologist and pharmacist you are on blood thinners before your first infusion, and make sure your clotting levels are being checked regularly as part of your monitoring plan.

Yes — the combination of trastuzumab and pertuzumab is a standard regimen for HER2-positive breast cancer, supported by ASCO and ESMO guidelines in both early and advanced settings. The two are designed to target HER2 from different binding sites and are routinely given together, usually alongside chemotherapy. This is a different situation from the anthracycline question; pertuzumab and trastuzumab are studied as a combination, not as a hazardous overlap.

Yes, always. Any doctor, dentist or pharmacist treating you needs to know you are receiving trastuzumab, because they may prescribe medicines that interact with it or with other drugs in your regimen. A dentist prescribing an antibiotic or anti-inflammatory, or a GP starting a new blood pressure medicine, may not know about your cancer treatment unless you tell them. Carry a current list of all your medicines to every medical or dental appointment.

Small amounts of alcohol are not directly contraindicated with trastuzumab, but alcohol adds stress to the heart and can worsen treatment-related fatigue and nausea. If you are receiving concurrent chemotherapy, alcohol's effects on immune function and recovery are also worth discussing with your team. Your oncologist is the right person to advise on your specific situation, particularly given the other drugs in your regimen.

Contact your oncology team the same day you realise it, even if you feel well. Most interactions do not cause immediate symptoms, but your team may want to check your heart function or blood results sooner than scheduled. Do not wait until your next infusion appointment. You will not be judged for the accident — prompt reporting is exactly what the team needs, and it gives them the best chance to monitor and respond quickly if anything needs attention.